Oral fluoropyrimidine versus intravenous 5‐fluorouracil for the treatment of advanced gastric and colorectal cancer: Meta‐analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|33|1|209-225

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.1, 2018-01, pp. : 209-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy

By Mastroianni Candida M.  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite

Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 191-197

Karger

Access to resources Recommend Favorite

Infusional 5-Fluorouracil and Mitomycin C: An Effective Regimen in the Treatment of Advanced Gastric Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 3, 2005-03 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

Combined Irinotecan, Oxaliplatin and 5-Fluorouracil in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 254-265

Karger

Access to resources Recommend Favorite

5-Fluorouracil, Mitomycin-C, and Polysaccharide-K versus Uracil-Ftorafur and Polysaccharide-K as Adjuvant Chemoimmunotherapy for Patients with Locally Advanced Gastric Cancer with Curative Resection

By  

Oncology Research and Treatment, Vol. 36, Iss. 7-8, 2013-06 ,pp. : 421-426

Karger

Access to resources Recommend Favorite